Erratum

This article refers to:

Spasticity in multiple sclerosis: results of a patient survey

In the International Journal of Neuroscience, 2013;123(6):400–8 for the article “Spasticity in multiple sclerosis: results of a patient survey,” errors have been noticed since publication. In Table 4, there was a formatting issue in the p-value column within the “Visits to specialist per year; n(%)” section. The table should have appeared as follows:

Table 4.   Resource consumption by MS patients with and without spasticity.

Resource	No spasticity (n = 407)	Spasticity (n = 1333)	p-value
Requires a carer; n (%)	18 (4.4)	224 (16.8)	<0.001
Requires rehabilitation sessions; n (%)	43 (10.6)	544 (40.8)	<0.001
Requires MS disability subsidies; n (%)	108 (26.5)	794 (59.6)	<0.001
Disability grade			<0.001
<33%	28 (25.9)	77 (9.7)	<0.001
33%–65%	58 (54)	324 (41)	0.013
>65%	15 (13.9)	252 (31.7)	0.002
33%–65% with reduced mobility	7 (6.5)	141 (17.8)	<0.001
Requires mobility aid; n (%)	21 (5.6)	514 (41.7)	<0.001
Type of aid
Crutch	5 (23.8)	127 (24.7)	<0.001
Walking stick	8 (38.0)	110 (21.0)	<0.001
Wheelchair	4 (19.0)	211 (41.1)	<0.001
Bed-bound	0 (0)	2 (0.4)	<0.001
Other	4 (19.0)	64 (12.5)	<0.001
Visits to specialist per year; n (%)			0.007
1 visit	62 (16.8)	137 (11.1)	0.005
2–>4 visits	271 (73.2)	888 (72.3)	NS
On demand	37 (10.0)	204 (16.6)	0.002
MSS medication; n (%)
None	–	635 (50.0)	–
Taking currently	–	384 (30.2)	–
Taken in past	–	86 (6.8)	–
Not known	–	165 (13.0)	–
Number of medications
Mean (SD)		1.58 (0.91)	–
Median (range)		1.00 (1–10)	–
Alternative therapies; n (%)	68 (16.7)	241 (18.1)	NS

The publishers apologise for this error.